Vikas P. Sukhatme, MD, ScD, dean of Emory Faculty of Drugs, has introduced that he’ll step down as dean of the college and chief educational officer of Emory Healthcare in March 2023 after 5 years of service within the roles.
He’ll proceed as a full-time college member within the Faculty of Drugs, main the Morningside Heart for Modern and Inexpensive Drugs (Morningside Heart) and contributing to a nascent “Clinics of the Future” initiative in addition to instructing.
“Dean Sukhatme has been transformational as chief of the Emory Faculty of Drugs,” says Emory President Gregory L. Fenves. “He set bold targets — in coaching, college recruitment and analysis to deal with and treatment ailments — and exceeded them. I’m grateful for the dedication he confirmed over the previous 5 years. He elevated the Faculty of Drugs and set it on a path for continued success.”
As dean of Emory’s largest faculty, Sukhatme has led greater than 3,300 full- and part-time college and almost 2,500 workers members, together with greater than 1,300 residents and fellows who prepare in 112 ACGME-accredited packages. The varsity has greater than 1,000 college students, with 593 within the MD program and 485 learning in 5 educational well being packages.
Throughout his deanship, Sukhatme’s focus has been on eradicating boundaries to medical innovation and discovering new, significant methods to combine analysis into training and affected person care — with the last word purpose of enhancing well being outcomes everywhere in the world.
“Vikas has been a useful chief all through the well being sciences with a powerful dedication to discovery, training and affected person care,” says David S. Stephens, interim govt vp for well being affairs. “Whereas we are going to tremendously miss his contributions and efforts as a member of the management staff, we’re supportive of Vikas’ want to dedicate extra time to household and delighted that he’ll proceed advancing Emory’s missions, notably by means of his work with the Morningside Heart.”
“The Faculty of Drugs, Emory Healthcare, the Woodruff Well being Sciences Heart and the college at massive have benefitted from Vikas’ considerate management based on collaboration, innovation and excellence, and his drive to extend SOM’s NIH funding, in addition to his reward for recruiting unbelievable students,” says Ravi V. Bellamkonda, provost and govt vp for tutorial affairs. “We’re grateful to Vikas for his dedication to making sure a easy transition and his continued steerage as we proceed to construct upon the excellent progress he has remodeled the previous 5 years.”
Stephens and Bellamkonda famous that subsequent steps for Faculty of Drugs management can be introduced within the coming weeks in session with incoming Government Vice President for Well being Affairs Ravi Thadhani.
In a Nov. 22 message to the Faculty of Drugs group, Sukhatme expressed gratitude for the group’s braveness in rising to the problem of the COVID-19 pandemic, in addition to delight in collective progress made towards the college’s Excellence to Eminence strategic plan.
“Now we have come a great distance collectively … and there may be loads of momentum and help to hold us ahead,” he wrote within the message. “I’ve super confidence within the present and future management of President Fenves, Provost Bellamkonda, interim EVPHA David Stephens and incoming EVPHA Ravi Thadhani, in addition to the excellent management staff within the SOM … We is not going to miss a beat!”
From excellence to eminence
Sukhatme got here to Emory in 2017 from Harvard Medical Faculty, the place he served for eight years as chief educational officer and Harvard college dean for tutorial packages at Beth Israel Deaconess Medical Heart in Boston. He has an intensive background in collaborative analysis and is a powerful proponent of translational medication.
Sukhatme has famous that his choice to hitch Emory Faculty of Drugs was fueled by the idea that we live at a singular time in biomedical historical past, throughout which a revolution in complementary forces is altering the best way we consider medication. “I believed — and nonetheless consider — that Emory has the correct mix of college excellence, collaborative spirit and strategic partnerships to sort out a number of the most intractable issues in medication with an honest shot at success,” says Sukhatme.
To assist handle these challenges, he oversaw growth of the Faculty of Drugs’s Excellence to Eminence strategic plan, which has included recruitment of greater than 90 eminent college, together with “sport changers” whose transformative concepts in biomedical science may change the apply of medication. On the identical time, he invested in present college by means of packages just like the Think about, Innovate, Influence awards (I3), which have spurred collaboration and new concepts. These seed grants have resulted in an ROI of greater than 6:1 thus far.
Together with Stephens and different leaders within the well being sciences, Sukhatme acknowledged the necessity for enhanced analysis infrastructure to help the rising analysis enterprise, and co-led building and programming of the Well being Sciences Analysis Constructing II, Emory’s largest analysis constructing thus far, scheduled to open in spring 2023.
He has labored to raise help for innovation and entrepreneurship at Emory, regularly espousing the values that he considers key drivers for innovation: acceleration, boldness, connectivity, data-driven, engagement and inclusion, and fun.
In fact, COVID-19 was not a part of the strategic plan. “I didn’t anticipate a worldwide pandemic occurring throughout my tenure or the following tumultuous instances, but each one among you rose to the problem with outstanding braveness and resilience,” Sukhatme says in a message to the Faculty of Drugs group. “For that I can not thanks sufficient: I’m so grateful and proud.”
Regardless of the challenges, the Faculty of Drugs analysis enterprise continued to achieve new heights underneath Sukhatme’s management, seeing important progress within the complete variety of NIH-funded investigators and reaching a complete of $588 million in analysis funding in FY22.
Reworking training and specializing in individuals
Emory Faculty of Drugs’s academic packages are extremely ranked and extensively identified for producing superior medical suppliers and excellent scientists. Over the previous yr, Sukhatme has partnered with Government Affiliate Dean J. William Eley, MD, MPH, and different stakeholders throughout the college to launch an “training transformation” throughout all diploma packages within the SOM.
Incorporating novel content material and pedagogical strategies with a concentrate on lifelong studying, the transformation is meant to make sure the Faculty of Drugs’s curriculum is maintaining with the calls for on clinicians and scientists to resolve the well being challenges we face at present and sooner or later.
Below Sukhatme’s management, the medical faculty’s pupil physique has grow to be more and more numerous. Thirty p.c of Emory’s present medical pupil inhabitants establish as traditionally underrepresented in medication (URiM). The first Variety, Fairness and Inclusion strategic plan for the Faculty of Drugs was additionally launched and is being carried out now. “I’m … thrilled with the progress of our training transformation initiative, and the early affect of our first range, fairness and inclusion strategic plan,” says Sukhatme.
He’s passionate in regards to the distinctive and essential function physicians and scientists should play in addressing inequity. “The world we’re dwelling in at present is changing into an increasing number of fractured, however medication has an unbelievable energy to heal and to attach — throughout race, throughout non secular beliefs, throughout all the things.”
One instance of Sukhatme’s concentrate on innovation to make good well being extra accessible to all is the creation of the Morningside Heart for Modern and Inexpensive Drugs, an interdisciplinary unit inside the Woodruff Well being Sciences Heart. The heart was co-founded by Sukhatme and his spouse, Vidula Sukhatme, MS, to advertise analysis, training and advocacy relating to the important have to repurpose medicine and different therapies that aren’t being pursued as a consequence of an absence of enough monetary incentive.
Submit deanship, Sukhatme plans to stay lively on the drugs full-time college, main the Morningside Heart and Clinics of the Future initiative. He can even interact in instructing actions within the Faculty of Drugs and throughout Emory.